HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The endothelium of basilar artery of diabetic rat treated with epoetin delta.

Abstract
Erythropoiesis-stimulating agents (ESAs) are used to treat anemia associated with renal failure. It is now known that these agents also show a broad range of cell- and tissue-protective effects. In the current study, we explored whether an ESA, epoetin delta, affects vascular pathology linked to diabetes mellitus (DM). In a rat model of streptozotocin-induced DM, we investigated, by pre-embedding electron-immunocytochemistry, whether epoetin delta affects DM-induced structural changes in cerebrovascular endothelium of the rat basilar artery and influences the subcellular distribution of endothelial nitric oxide synthase (eNOS). Epoetin delta treatment influenced DM-induced changes to the distribution of eNOS in, and the structure of, the endothelial cell. This may indicate potential beneficial effects of epoetin delta on cerebrovascular endothelium and suggests eNOS as a possible target molecule of epoetin delta in DM.
AuthorsAndrzej Loesch, Helen Tang, Mary A Cotter, Norman E Cameron
JournalAngiology (Angiology) Vol. 61 Issue 4 Pg. 405-14 (May 2010) ISSN: 1940-1574 [Electronic] United States
PMID19815604 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Recombinant Proteins
  • Erythropoietin
  • epoetin delta
  • Streptozocin
  • Nitric Oxide Synthase Type III
Topics
  • Animals
  • Basilar Artery (drug effects, enzymology, pathology)
  • Diabetes Mellitus, Experimental (drug therapy, enzymology, pathology)
  • Endothelial Cells (drug effects, enzymology, pathology)
  • Endothelium, Vascular (drug effects, enzymology, pathology)
  • Erythropoietin (pharmacology)
  • Male
  • Nitric Oxide Synthase Type III (metabolism)
  • Rats
  • Rats, Sprague-Dawley
  • Recombinant Proteins
  • Streptozocin

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: